Is India immune to coronavirus?

India coronavirus covid-19 growth

11 March 2020
| By Oksana Patron |
image
image
expand image

Although the coronavirus is not expected to stop India’s structural growth, it will impact global growth in at least the first half of 2020 and therefore India’s growth, India Avenue Investment Management said.

Investors should be reminded that even though India did not have significant links to the global supply chain (exports are only 11% of gross domestic product), it benefited when global growth was strong given comparative advantages in exports of refined petrochemicals/oils, gems/precious stones, textiles, electronics, pharmaceuticals and automobiles.

“As we have always articulated to investors, India is a market where you should build exposure during dire times as the structural story will outlast any cyclical events. It’s a matter of portfolio construction and investment horizon,” India Avenue said in a note.

“When it comes to satellite investments like investing in India, investors typically tend to sell during adversity and buy during euphoria.”

However, the virus still had potential to become the key risk for India, given it would make itself a home amongst India’s significant population of 1.3 billion and its potential for it to spread quickly, without appropriate healthcare systems and medication for all.

According to India Avenue, while it was hard at this point to estimate the potential damage to markets, there were some positives such as:

  • US$475 billion ($730.3 billion) of forex reserves to defend the currency if required 
  • A substantial fall in the oil price which will reduce inflationary pressures in India (India imports over 80% of its oil usage)
  • Central Bank potential to cut cash rates from 5.15%
  • Fiscal stimulus likely to be forth coming
  • Potential to replace China in certain aspects of the global supply chain, given most are now seeking diversity of supply. Foreign direct investment in India has increased significantly over the last 12 months (US$175 billion vs US$87 billion previous year)

“We think it is inevitable that India starts its recovery in in the 2H21 i.e. Sept 2020 onwards. It is not very often that you can identify an investment where you can buy quality growth stocks at P/E’s in the teens and cyclical growth for single digit P/E’s in a market like India. We are re-aligning our fund to go overweight in the both these segments,” the manager said.

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

James Patterson

How much did IRESS pay Deloitte for this analysis? Not sure they are the arbiter of intelligent forecasting in this spac...

18 hours ago
Howard Elton

Article makes no comment that the advisers leaving industry are older and have many years of work an life experience w...

2 days ago
Peter Robinson

This article appears to overlook the fact that there must be a fairly large group of advisers who missed out on the expe...

2 days ago

ASIC has secured travel restraint orders against a financial adviser while he is the subject of an investigation into alleged financial misconduct....

4 days 19 hours ago

Insignia Financial has unveiled a new operating model and executive team, including a new head of advice, while three senior executives are set to depart the licensee....

2 weeks 2 days ago

Analysis by Chant West of the annual performance of growth superannuation funds has uncovered which ones see the best performance....

1 week 1 day ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND
Fund name
3y(%)pa
1
Ardea Diversified Bond F
144.00 3 y p.a(%)
3
Hills International
63.39 3 y p.a(%)